Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manisha Palta

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
The Lancet. Oncology|December 1, 2023
Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trialCullen M Taniguchi, Jessica M Frakes, Todd A Aguilera, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2021
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Michael I D'Angelica, Daniel E Abbott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 10, 2025
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyAl B Benson, Michael I D'Angelica, Thomas Abrams, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023Al B Benson, Michael I D'Angelica, Thomas Abrams, et al.
JAMA Surgery|December 4, 2024
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal AdenocarcinomaJordan M Cloyd, Angela Sarna, Matthew J Arango, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
The Lancet. Oncology|December 1, 2023
Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trialCullen M Taniguchi, Jessica M Frakes, Todd A Aguilera, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2021
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Michael I D'Angelica, Daniel E Abbott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 10, 2025
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyAl B Benson, Michael I D'Angelica, Thomas Abrams, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023Al B Benson, Michael I D'Angelica, Thomas Abrams, et al.
JAMA Surgery|December 4, 2024
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal AdenocarcinomaJordan M Cloyd, Angela Sarna, Matthew J Arango, et al.
Pageof 10